Novartis follows up on big CAR-T win by naming Vas Narasimhan as its new CEO
Novartis, one of the world’s biggest spenders on drug R&D, will soon be run by a development expert.
The pharma giant announced Monday morning …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
